ALBANY, N.Y.--(BUSINESS WIRE)--
AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical
devices for the minimally-invasive treatment of cancer and peripheral
vascular disease, announced today that it will present at the 29th
Annual J.P. Morgan Healthcare Conference at 2 p.m. PT on Thursday,
January 13, 2011, at the Westin St. Francis Hotel in San Francisco,
Calif. Jan Keltjens, President and Chief Executive Officer of
AngioDynamics, will review the Company's business strategy and recent
corporate developments.
A live webcast of AngioDynamics' presentation may be accessed through
the investor relations section of the Company's Web site at http://investors.angiodynamics.com,
where an archived replay of the presentation also will be available for
90 days after the live presentation.
About AngioDynamics
AngioDynamics, Inc. is a leading provider of innovative medical devices
used by interventional radiologists, surgeons and other physicians for
the minimally-invasive treatment of cancer and peripheral vascular
disease. AngioDynamics' diverse product lines include market-leading
radiofrequency and irreversible electroporation ablation systems,
vascular access products, angiographic products and accessories,
dialysis products, angioplasty products, drainage products, thrombolytic
products, embolization products and venous products. More information is
available at www.angiodynamics.com.
AngioDynamics, Inc.
D. Joseph Gersuk, CFO,
800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
or
EVC
Group, Inc.
Doug Sherk, 415-896-6820 (Investor Relations)
dsherk@evcgroup.com
Greg
Gin, 646-445-4801 (Investor Relations)
ggin@evcgroup.com
Chris
Gale, 646-201-5431 (Media)
cgale@evcgroup.com
Source: AngioDynamics
News Provided by Acquire Media
